RPRoberto Presta

Roberto Presta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roberto Presta has a total of 185 co-authors. Here are the top co-authors by number of shared publications:

  • Mario Bo

    Section of Geriatrics, Department of Medical Sciences, University of Turin, Città della Salute e delle Scienze Molinette, Turin, Italy

    22 shared publications
  • Enrico Brunetti

    Section of Geriatrics, Department of Medical Sciences, Molinette Hospital, University of Turin, Città della Salute e della Scienza, Turin

    16 shared publications
  • Gianluca Isaia

    Division of Geriatrics, Department of General and Specialistic Medicine, Città della Salute e della Scienza University Hospital, Turin, Italy

    7 shared publications
  • Andrea Ungar

    Division of Geriatric and Cardiogeriatric Medicine, Department of Experimental and Clinical Medicine, University of Florence, Careggi University Hospital, Florence, Italy

    5 shared publications
  • Luigi Biancone

    Division of Nephrology Dialysis and Transplantation, Department of Medical Sciences, Città Della Salute e Della Scienza Hospital, University of Turin, Turin, Italy

    4 shared publications
  • Marco Inzitari

    RE-FiT Barcelona Research Group, Vall d’Hebron Institute of Research (VHIR) and Parc Sanitari Pere Virgili, Barcelona, Spain

    4 shared publications

Latest Publications

  • Prevalence and severity of frailty in patients admitted to Hospital-at-Home: a scoping review

    by Enrico Brunetti, Roberto Presta, Giulia Rivasi, Laura Mónica Pérez Bazán, Marco Inzitari, Vittoria Tibaldi, Renata Marinello, Mario Bo

  • Open Access

    Organizational profiles of bed-based intermediate care services in Italy: a network-based cross-sectional survey

    by Roberto Presta, Caterina Salucci, Enrico Benvenuti, Mario Bo, Francesco Caronzolo, Lorenzo Espa, Giovanni Gelmini, Paola Maina, Sara Salini, Antonio Cherubini, et al.

  • Open Access

    Major structural and functional heterogeneity in Italian intermediate care: a national SIGG survey

    by Roberto Presta, Caterina Salucci, Enrico Benvenuti, Mario Bo, Francesco Caronzolo, Lorenzo Espa, Giovanni Gelmini, Paola Maina, Sara Salini, Antonio Cherubini, et al.

    Intermediate care (IC) is expanding in Italy, but the same label may refer to services with different organization and capabilities. We conducted a national cross-sectional e-survey promoted by the Italian Society of Gerontology and Geriatrics (SIGG) to compare three self-identified inpatient intermediate care settings: rehabilitation and functional recovery IC units (RFR-IC; n = 29), Community Hospitals (n = 14), and subacute units (n = 15). Among 58 facilities, marked heterogeneity emerged across core domains. Admissions from acute wards were nearly universal (94.8%), while admission from home was more frequent in RFR-IC and Community Hospitals than in subacute units (79.3%, 78.6%, and 26.7%; p = 0.002). Clinical stability was commonly assessed without a formal tool across settings (58.6%), while the National Early Warning Score was mainly adopted in Community Hospitals (31.0% vs 64.3% vs 26.7%; p = ns). Rehabilitation/reactivation as care goal was mainly reported in RFR-IC (79.3% vs 28.6% and 53.3%; p = 0.005), whereas shorter stays were more common in Community Hospitals and subacute units. Multidisciplinary staffing and diagnostic resources also differed. This heterogeneity suggests that IC in Italy still represents an umbrella term and reinforces the need for a clearer operational framework with minimum standards for admission, staffing, diagnostics, and length of stay.

  • Diagnostic uncertainties in older inpatients with suspected heart failure with preserved ejection fraction: a pilot cohort study

    by Roberto Presta, Enrico Brunetti, Francesco Palmas, Simone Carlone, Clara Musarò, Elena Cane, Marco Milan, Guido Sergio Giorgio Maggiani, Gianluca Isaia, Angela Sciacqua, et al.

    Heart failure (HF) with preserved ejection fraction (HFpEF) is increasingly suspected in older adults. However, diagnosis remains challenging due to nonspecific symptoms, age-related structural cardiac changes, and confounding comorbidities. Reliability of algorithms developed in younger populations may be limited in this population. This prospective study enrolled inpatients aged > 75 years with at least one ESC-listed typical sign/symptom suggestive of HF and no prior HF diagnosis were evaluated for HFpEF using ESC 2021 criteria. Structural/functional transthoracic echocardiographic (TTE) abnormalities and age-adjusted NT-proBNP thresholds were recorded. Diagnostic accuracy of the H2FPEF and HFA-PEFF scores was evaluated. We also tested a modified HFA-PEFF score incorporating age-adjusted thresholds for NT-proBNP and for septal/lateral e’ velocity. Among 200 inpatients (median age 86.6 years, 58.0% women), 96.0% fulfilled ESC criteria, with TTE abnormalities almost universal (95.0%), mainly left atrial enlargement (70.0%) and increased wall thickness (66.5%). However, only 52.0% had elevated age-adjusted NT-proBNP. Notably, confounding comorbidities were very frequent (98.0%), particularly chronic kidney disease (60.0%) and infections (40.0%). Using rule-in cut-offs, H₂FPEF score identified few high-probability cases (7.0%) with very low sensitivity (0.07) and perfect specificity (1.00; AUROC 0.676). HFA-PEFF classified 67.5% of patients as high probability, with better accuracy (sensitivity 0.69, specificity 0.75; AUROC 0.856). The modified HFA-PEFF increased specificity (1.00) but reduced sensitivity (0.36), improving AUROC to 0.908 and lowering false positives. HFpEF diagnosis in older inpatients is complicated by overlapping comorbidities and age-related cardiac changes. Standard algorithms may misclassify patients and do not reflect true disease burden. Incorporating age-adjusted parameters in scores may improve specificity and support better clinical decision-making, but validation in larger studies is needed.


  • Association Between Symptoms of Anxiety and Depression and Blood Pressure Variability in Older Outpatients

    by Roberto Presta, Giulia Rivasi, Alice Ceccofiglio, Sara Rogani, Laura Orlandi, Ludovica Ceolin, Luigi Scavino, Alessandro Mengozzi, Enrico Brunetti, Chiara Mussi, et al.

    Introduction Blood pressure variability (BPV) predicts cardiovascular risk beyond average BP, but evidence on the role of anxiety/depression on BPV in older adults is limited. Aim To evaluate the association of anxiety and depressive symptoms with short-term BPV and white-coat effect (WCE) in older outpatients undergoing ambulatory blood pressure monitoring (ABPM). Methods Cross-sectional multicenter study of outpatients aged ≥ 65 years undergoing 24-h ABPM across Italian geriatric centers. Anxiety and depressive symptoms were assessed with GAD-7, STAI-Y1/Y2 and GDS-15. Short-term BPV was quantified by daytime systolic average real variability (ARV). The office-daytime BP difference was calculated (ΔSBP and ΔDBP), and WCE was defined categorically as ΔSBP ≥ 20 mmHg and/or ΔDBP ≥ 10 mmHg. Multivariable models were adjusted for clinical and pharmacological confounders. Results Among 235 outpatients (median age 76.4 years, 60.0% female), anxiety prevalence varied widely by scale (GAD-7: 34.9%; STAI-Y1: 74.0%; STAI-Y2: 73.2%), while depressive symptoms were present in 28.5%. ARV did not significantly differ in patients screening positive or negative for anxiety (GAD-7: 16.4 vs 15.5 mmHg, p = 0.349; STAI-Y1: 16.2 vs 14.9 mmHg, p = 0.214; STAI-Y2: 16.2 vs 14.8 mmHg, p = 0.160), or between those with and without depressive symptoms (15.9 vs 15.8 mmHg, p = 0.902); also, after adjustment for potential confounders. WCE prevalence was 40.9% and was higher in participants screening negative for depressive symptoms (39.2% vs 23.9%, p = 0.039). ΔSBP tended to be higher in participants screening negative for anxiety (GAD-7: 7.6 vs 3.3 mmHg, p = 0.095) and depressive symptoms (GDS-15: 7.6 vs 2.6 mmHg, p = 0.065). Conclusions Anxiety and depressive symptoms were not independently associated with short-term BPV in older outpatients. WCE/ΔSBP were generally higher, albeit non significantly, in participants without anxiety or depression. These findings suggest that psychological symptoms may contribute only modestly to short-term BP fluctuations in older adults. Graphical Abstract The alternative text for this image may have been generated using AI.

  • Need for reinforcing the identity of the intermediate care: an Italian perspective

    by Alessandro Morandi, Roberto Presta, Caterina Salucci, Enrico Benvenuti, Mario Bo, Francesco Caronzolo, Lorenzo Espa, Giovanni Gelmini, Paola Maina, Sara Salini, et al.


  • Oral anticoagulant nonprescription at discharge in geriatric patients with atrial fibrillation and reduced expected survival

    by Enrico Brunetti, Roberto Presta, Chukwuma Okoye, Claudia Filippini, Silvio Raspo, Gerardo Bruno, Marco Marabotto, Fabio Monzani, Angela Sciacqua, Mario Bo


  • Knowledge and attitudes towards generic medicines: Point of view of older patients and their caregivers

    by Ilaria Parrotta, Panaiotis Finamore, Enrico Brunetti, Roberto Presta, Giovanni Lazzaro, Priscilla Romagnoli, Rosa De Felice, Davide Maria Biancone, Marialucia Bursi, Chiara Petrucci, et al.

  • Open Access

    Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study

    by Carlo Fumagalli, Mattia Zampieri, Roberto Presta, Greta Pini, Giulia Vetere, Alessia Argirò, Simone Longhi, Giacomo Tini, Beatrice Musumeci, Giuseppe Limongelli, et al.

    BACKGROUND: The prevalence of transthyretin cardiac amyloidosis among older adults (often octogenarians) is increasing. We aimed to determine whether age and geriatric syndromes bear any impact on the management and outcomes in transthyretin cardiac amyloidosis and assess the risk of ageism. METHODS: In a prospective, multicenter cohort study, 256 patients diagnosed with transthyretin cardiac amyloidosis from March 2021 to March 2024 underwent comprehensive geriatric assessment (CGA). The study evaluated the prevalence and clinical associations of CGAs across different disease stages (National Amyloidosis Centre stage). Key CGA domains included disability, malnutrition, depression, frailty, Short Physical Performance Battery, and cumulative deficits (sum of the single CGA items). Associations of these measures with disease-modifying therapy and overall mortality were analyzed. RESULTS: Median age was 82 years (men: n=223 [87%]; variant: n=19 [7.4%]); 129 (50.3%) patients received disease modifiers. Those ≥85 years had significantly lower odds of receiving disease-modifying therapy even after adjusting for disability, frailty, and cumulative deficits. Over 1.9 (interquartile range, 1.0–2.3) years, 45 (17.6%) patients died. After adjustment for National Amyloidosis Centre stage, diuretics and disease modifiers, CGA domains of disability, malnutrition, Short Physical Performance Battery, frailty, and number of deficits, but not age, were significantly associated with mortality. Assessment of CGA domains improved National Amyloidosis Centre prognostic accuracy. CONCLUSIONS: In a national prospective cohort of patients with transthyretin cardiac amyloidosis, older age was associated with lower prescription of disease modifiers, even among individuals with a low burden of geriatric syndromes. However, when adjusted for geriatric domains, age was not associated with survival, indicating potential ageism. Because some geriatric syndromes may be modifiable, a CGA could enhance risk stratification, reduce age-related bias, and improve outcomes.